40428-87-3

Basic information

• Product Name: Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI)
• Synonyms: Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI)
• CAS NO: 40428-87-3
• Molecular Formula: C₁₁H₁₄O
• Molecular Weight: 162.22826
• Product Categories: ISOPROPYL;ACETYLGROUP
• Mol File: 40428-87-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 84-90 °C(Press: 0.2 Torr)
• Appearance: /
• Density: 0.948±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI)(40428-87-3)
• EPA Substance Registry System: Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI)(40428-87-3)

Safety Data

• Hazardous Substances Data: 40428-87-3(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-[3-(1-methylethyl)phenyl]- (9CI) is a chemical compound with the molecular formula C11H14O. It is also known by the name 3-(1-methylethyl)acetophenone and belongs to the ketone class of organic compounds. This chemical is commonly used in the production of perfumes, flavorings, and pharmaceuticals due to its pleasant aroma and potential medicinal properties. It is also used as a fragrance ingredient in various cosmetic and personal care products. Additionally, it has been studied for its potential antimicrobial and antioxidant properties, making it a valuable compound in the development of new drugs and functional foods.

Upstream product

• 87771-42-4 1-(3-(prop-1-en-2-yl)phenyl)ethanone 
• 5433-01-2 1-bromo-3-isopropylbenzene 
• 78191-00-1 N-Methoxy-N-methylacetamide 
• 1429312-27-5 3-isopropyl-N-methoxy-N-methylbenzamide 
• 75-16-1 methylmagnesium bromide 
• 5651-47-8 3-isopropylbenzoic acid 
• 12203-34-8 (η(6)-iso-propylbenzene)chromium tricarbonyl 
• 13387-60-5 3-(2-hydroxy-2-propyl)-1-(2-hydroperoxy-2-propyl)benzene 
• 99-62-7 1,3-diisopropylbenzene 
• 80937-33-3 oxygen 
• 3748-13-8 1,3-bis(1-methylethenyl)-benzene 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 80841-09-4 meta-isopropylphenol trifluoromethanesulfonate 
• 75-05-8 acetonitrile 

Downstream Products

• 1194065-50-3 5-(1-(3-isopropylphenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 1438984-07-6 (S)-N-(1-(3-isopropylphenyl)ethyl)-1-(3-methoxybenzyl)-2-methyl-1H-benzo[d]imidazole-5-carboxamide 
• 1438984-08-7 (S)-1-(3-hydroxybenzyl)-N-(1-(3-isopropylphenyl)ethyl)-2-methyl-1H-benzo[d]imidazole-5-carboxamide 
• 1438984-09-8 (S)-methyl 2-(3-((5-(((S)-1-(3-isopropylphenyl)ethyl)carbamoyl)-2-methyl-1H-benzo[d]imidazol-1-yl)methyl)phenoxy)propanoate 
• 1438983-77-7 (S)-2-(3-((5-(((S)-1-(3-isopropylphenyl)ethyl)carbamoyl)-2-methyl-1H-benzo[d]imidazol-1-yl)methyl)phenoxy)propanoic acid 
• 1439933-29-5 (S)-N-((S)-1-(3-isopropylphenyl)ethyl)-2-methylpropane-2-sulfinamide 
• 1213971-65-3 (S)-1-(3-isopropylphenyl)ethanamine 
• 1438983-62-0 (S)-1-(4-chlorobenzyl)-N-(1-(3-isopropylphenyl)ethyl)-1H-benzo[d]imidazole-5-carboxamide 
• 1438984-02-1 (S,E)-N-(1-(3-isopropylphenyl)ethylidene)-2-methylpropane-2-sulfinamide 
• 1439933-15-9 (S)-3-(4-((5-((1-(3-isopropylphenyl)ethyl)carbamoyl)-1H-benzo[d]imidazol-1-yl)methyl)phenyl)picolinic acid 
• 1439933-38-6 (S)-methyl 3-(4-((5-((1-(3-isopropylphenyl)ethyl)carbamoyl)-1H-benzo[d]imidazol-1-yl)methyl)phenyl)picolinate 
• 1439933-37-5 (S)-N-(1-(3-isopropylphenyl)ethyl)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1H-benzo[d]imidazole-5-carboxamide 
• 1439933-36-4 (S)-1-(4-bromobenzyl)-N-(1-(3-isopropylphenyl)ethyl)-1H-benzo[d]imidazole-5-carboxamide 
• 457928-76-6 (E)-3-(3-isopropylphenyl)but-2-enoic acid ethyl ester 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

N-BENZYLBENZIMIDAZOLE MODULATORS OF PPARG

The invention provides molecular entities that bind with high affinity to PPARG (PPAR?), inhibit cdk5-mediated phosphorylation of PPARG, but do not exert an agonistic effect on PPARG. Compounds of the invention can be used for treatment of conditions in patients wherein PPARG plays a role, such as diabetes or obesity. Methods of preparation of the compounds, bioassay methods for evaluating compounds of the invention as non-agonistic PPARG binding compounds, and pharmaceutical compositions are also provided.

ARYLSUBSTITUTED THIAZOLOTRIAZOLES AND THIAZOLOIMIDAZOLES

This disclosure relates to compounds, compositions and methods for the treatment of various disorders. In particular, the disclosure relates to thiazolotriazole and thiazoloimidazole compounds which agonize the activity of the protein TGR5. Formula (I)